Delivra Health Brands Inc.
DHBUF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2,303 | $4,358 | $3,095 | $2,754 |
| % Growth | -47.2% | 40.8% | 12.4% | – |
| Cost of Goods Sold | $1,244 | $2,024 | $1,543 | $1,460 |
| Gross Profit | $1,058 | $2,334 | $1,552 | $1,294 |
| % Margin | 46% | 53.6% | 50.1% | 47% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1,077 | $1,195 | $1,098 | $1,040 |
| SG&A Expenses | $1,496 | $1,552 | $1,508 | $1,615 |
| Sales & Mktg Exp. | $419 | $309 | $410 | $575 |
| Other Operating Expenses | -$422 | $694 | $326 | $326 |
| Operating Expenses | $1,074 | $2,246 | $1,834 | $1,941 |
| Operating Income | -$16 | $311 | -$282 | -$647 |
| % Margin | -0.7% | 7.1% | -9.1% | -23.5% |
| Other Income/Exp. Net | -$50 | $527 | -$140 | -$165 |
| Pre-Tax Income | -$65 | $838 | -$422 | -$812 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$65 | $838 | -$422 | -$812 |
| % Margin | -2.8% | 19.2% | -13.6% | -29.5% |
| EPS | -0.002 | 0.012 | -0.014 | -0.026 |
| % Growth | -117.2% | 190.4% | 48.1% | – |
| EPS Diluted | -0.002 | 0.012 | -0.014 | -0.026 |
| Weighted Avg Shares Out | 31,262 | 31,262 | 31,262 | 31,262 |
| Weighted Avg Shares Out Dil | 31,262 | 31,262 | 31,262 | 31,262 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $51 | -$142 | $64 | $98 |
| Depreciation & Amortization | $27 | -$47 | $326 | $326 |
| EBITDA | $7 | $649 | -$32 | -$388 |
| % Margin | 0.3% | 14.9% | -1% | -14.1% |